Acute Myeloid Leukemia
A brief digest about this topic
Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, however, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work. In acute myeloid leukemia (AML), there are too many of a specific type of white blood cell called a myeloblast.
AML is the most common type of acute leukemia in adults. This type of cancer usually gets worse quickly if it is not treated. Possible risk factors include smoking, previous chemotherapy treatment, and exposure to radiation.
Symptoms of AML include:
- Fever
- Shortness of breath
- Easy bruising or bleeding
- Bleeding under the skin
- Weakness or feeling tired
- Weight loss or loss of appetite
Tests that examine the blood and bone marrow diagnose AML. Treatments include chemotherapy, other drugs, radiation therapy, stem cell transplants, and targeted immune therapy. Once the leukemia is in remission, you need additional treatment to make sure that it does not come back.
NIH: National Cancer Institute
Provided by: NIH - National Institute of Health
Links shared publicly online about this topic
What Is Acute Myeloid Leukemia? What Causes Acute Myeloid Leukemia?
medicalnewstoday.com — “Acute myeloid leukemia, also known as acute myeloblastic leukemia, acute myelogenous leukemia, acute nonlymphocytic leukemia, AML, or ANLL is a fast-growi” View full resource at medicalnewstoday.com
Most Recently Shared on February 3, 2011 at 4:05 pm By:
What Is Acute Myeloid Leukemia? What Causes Acute Myeloid Leukemia? http://mnt.to/3QML #healthnews
Acute Myeloid Leukemia, Not Otherwise Categorized: eMedicine Pathology
emedicine.medscape.com — “Overview: In the World Health Organization (WHO) classification system,1 the category acute myeloid leukemia not otherwise categorized (now refered to as 'not otherwise specified') includes those types of acute myeloid leukemia (AML) that are not associated with ...” View full resource at emedicine.medscape.com
Most Recently Shared on February 12, 2010 at 6:20 pm By:
Medscape Pathology Health Site
What entities are considered acute myeloid leukemia, not otherwise categorized? Find out at: http://bit.ly/aIivBo
Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA
medicalnewstoday.com — “Abbott (NYSE: ABT) announced it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid in determining the prognosis of patients with acu” View full resource at medicalnewstoday.com
Most Recently Shared on October 28, 2011 at 9:05 am By:
Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA http://t.co/n6PPrUUb #lymphoma #leukemia
Acute Myeloid Leukemia: Novel Developments In Treatment And Diagnosis Patients With Acute Myeloid Leukemia Receive Unnecessary High Doses Chemotherapy
medicalnewstoday.com — “Patients with the most common form of leukemia (acute myeloid leukemia) receive ten times more chemotherapy than necessary. This was revealed by a team of Dutch hematologists. 'It is expected that” View full resource at medicalnewstoday.com
Most Recently Shared on June 10, 2011 at 7:05 am By:
Acute Myeloid Leukemia: Novel Developments In Treatment And Diagnosis Patients With Acute Myeloid Leukemia Receive Unn... http://mnt.to/3WZn
RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
jco.ascopubs.org — “RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group” View full resource at jco.ascopubs.org
Most Recently Shared on October 7, 2011 at 2:14 pm By:
@eyoste The article I quoted is at http://t.co/PwAhyGkL And another one on RUNX1 Mutations in Acute Myeloid Leukemia at http://t.co/HxOGfkQb
RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
jco.ascopubs.org — “RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group” View full resource at jco.ascopubs.org
Most Recently Shared on April 18, 2011 at 1:01 am By:
G Garcia-Manero Doctor, Internist, Oncologist, and Physician
Mutations of RUNX1 in AML confer poor prognosis... http://fb.me/wnJlcefH
Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
jco.ascopubs.org — “Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group” View full resource at jco.ascopubs.org
Most Recently Shared on August 3, 2011 at 3:26 pm By:
G Garcia-Manero Doctor, Internist, Oncologist, and Physician
Molecular monitoring of NPM1 mutations predicts for survival in patients with AML in remission.This is an amazing... http://fb.me/MM9t0tCl
Access : Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias : Leukemia
nature.com — “Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.” View full resource at nature.com
Most Recently Shared on May 1, 2011 at 8:21 pm By:
G Garcia-Manero Doctor, Internist, Oncologist, and Physician
Mutations in TET2 can predict response to azacitidine... http://fb.me/JsPOm2f6
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605
bloodjournal.hematologylibrary.org — “A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605” View full resource at bloodjournal.hematologylibrary.org
Most Recently Shared on August 3, 2011 at 3:12 pm By:
G Garcia-Manero Doctor, Internist, Oncologist, and Physician
http://bloodjournal.hematologylibrary.org/content/118/3/523.abstract?sid=963295ad-24bf-4b40-85e7-f417f8a657b0 Len... http://fb.me/BicxwtQq
Cytarabine Dose of 36 g/m2 Compared With 12 g/m2 Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study
jco.ascopubs.org — “Cytarabine Dose of 36 g/m2 Compared With 12 g/m2 Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study” View full resource at jco.ascopubs.org
Most Recently Shared on August 3, 2011 at 3:18 pm By:
G Garcia-Manero Doctor, Internist, Oncologist, and Physician
This is a complicated trial of high dose ara-C after double induction. This is an European study using... http://fb.me/I1jL2Kew
Multivariate Analysis of Response and Survival After Treatment With Clofarabine, Cytarabine, and G-CSF Priming (GCLAC) in Relapsed/Refractory Acute Myeloid Leukemia: Comparison With Prior Experience Using Fludarabine and Cytarabine Combination Regimens -
oncologynurseadvisor.com — “Pamela S. Becker, MD, PhD, at University of Washington in Seattle, Wash., and colleagues conducted a study that indicated priming with clofarabine, cytarabine, and granulocyte colony-stimulating factor (G-CSF) (GCLAC) is active in relapsed and refractory acute myeloid leukemia (AML). Results of this study were presented at the 52nd American Society of Hematology Meeting and Exposition.” View full resource at oncologynurseadvisor.com
Most Recently Shared on December 5, 2010 at 4:32 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Multivariate Analysis of Response and Survival After Treatment With Clofarabine, Cytarabine… http://goo.gl/fb/vRLof
Oncology Article | Leukemia, Myeloid Leukemia, Myeloid, Acute
mdlinx.com — “Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate” View full resource at mdlinx.com
Most Recently Shared on December 16, 2010 at 6:31 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate: J... http://bit.ly/fsGW8P #oncology
Oncology Article | Leukemia, Myeloid, Acute
mdlinx.com — “RUNX1 mutations in acute myeloid leukemia: Results from a comprehensive genetic and clinical analysis from the AML Study Group” View full resource at mdlinx.com
Most Recently Shared on March 2, 2011 at 11:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
RUNX1 mutations in acute myeloid leukemia: Results from a comprehensive genetic and clinical analysis ... http://bit.ly/iifzI0 #oncology
Drug Therapy Leukemia, Myeloid, Acute on #MDlinx
mdlinx.com — “Drug Therapy Leukemia, Myeloid, Acute on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 26, 2010 at 6:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Infusion of HLA-mismatched peripheral blood stem cells improves outcome of chemotherapy for acute myeloid... http://bit.ly/btXfQD #oncology
Oncology Article | Leukemia, Myeloid, Acute
mdlinx.com — “Long-term prognosis of acute myeloid leukemia according to the New Genetic Risk Classification of the European LeukemiaNet recommendations: Evaluation of the proposed reporting system” View full resource at mdlinx.com
Most Recently Shared on June 3, 2011 at 9:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Long-term prognosis of acute myeloid leukemia according to the New Genetic Risk Classification of the ... http://bit.ly/jJCnFC #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Health News
Featured health news published by Medical News Today and chosen by the editorial team.
-
Medscape Pathology
Latest medical news, articles, and features from Medscape Pathology.
-
MNT Leukemia
The latest lymphoma and leukemia news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
